Terms ending in 2040
Otsuka Pharmaceutical Co., Ltd.
Every in-force patent on Otsuka Pharmaceutical Co., Ltd.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,796,688 | Disinfectant Composition In force · High confidence | Otsuka Pharmaceutical Factory, Inc. | In force | High confidence | |
| US 12,195,496 | 2'-Deoxy-2',2'-Difluorotetrahydrouridines with High Purity and Methods of Making the Same In force · Medium confidence | Taiho Pharmaceutical Co., Ltd. | In force | Medium confidence | |
| US 12,102,996 | Reaction Method, and Reaction System and Reaction Device Implementing Same In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence | |
| US 11,819,337 | Ingestible Electronic Medical Device In force · High confidence | Otsuka Pharmaceutical Co., Ltd. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Otsuka Pharmaceutical Co., Ltd..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.